CY1109018T1 - Φαρμακευτικη συνθεση που περιεχει ενα αλας μιρταζαπινης - Google Patents
Φαρμακευτικη συνθεση που περιεχει ενα αλας μιρταζαπινηςInfo
- Publication number
- CY1109018T1 CY1109018T1 CY20091100481T CY091100481T CY1109018T1 CY 1109018 T1 CY1109018 T1 CY 1109018T1 CY 20091100481 T CY20091100481 T CY 20091100481T CY 091100481 T CY091100481 T CY 091100481T CY 1109018 T1 CY1109018 T1 CY 1109018T1
- Authority
- CY
- Cyprus
- Prior art keywords
- salt
- mirtazapin
- pharmaceutical composition
- composition containing
- mirtazapine
- Prior art date
Links
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical class C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 abstract 1
- RONZAEMNMFQXRA-INIZCTEOSA-N LSM-5894 Chemical compound C1C2=CC=CN=C2N2CCN(C)C[C@H]2C2=CC=CC=C21 RONZAEMNMFQXRA-INIZCTEOSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000001530 fumaric acid Substances 0.000 abstract 1
- 150000002688 maleic acid derivatives Chemical class 0.000 abstract 1
- 229960001785 mirtazapine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04101664 | 2004-04-21 | ||
| EP05740221A EP1729777B1 (en) | 2004-04-21 | 2005-04-19 | Pharmaceutical composition comprising a salt of mirtazapine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1109018T1 true CY1109018T1 (el) | 2014-07-02 |
Family
ID=34928990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100481T CY1109018T1 (el) | 2004-04-21 | 2009-05-05 | Φαρμακευτικη συνθεση που περιεχει ενα αλας μιρταζαπινης |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20070111993A1 (https=) |
| EP (1) | EP1729777B1 (https=) |
| JP (2) | JP5260959B2 (https=) |
| CN (2) | CN1942191B (https=) |
| AR (1) | AR049028A1 (https=) |
| AT (1) | ATE424210T1 (https=) |
| AU (1) | AU2005235383B2 (https=) |
| BR (1) | BRPI0509953A (https=) |
| CA (1) | CA2561281C (https=) |
| CY (1) | CY1109018T1 (https=) |
| DE (1) | DE602005013066D1 (https=) |
| DK (1) | DK1729777T3 (https=) |
| EC (1) | ECSP066938A (https=) |
| ES (1) | ES2321961T3 (https=) |
| HR (1) | HRP20090190T1 (https=) |
| IL (1) | IL178201A (https=) |
| LV (1) | LV13556B (https=) |
| MX (1) | MXPA06011830A (https=) |
| MY (1) | MY144899A (https=) |
| NO (1) | NO20065077L (https=) |
| NZ (1) | NZ550052A (https=) |
| PE (1) | PE20060400A1 (https=) |
| PL (1) | PL1729777T3 (https=) |
| PT (1) | PT1729777E (https=) |
| RS (1) | RS50764B (https=) |
| RU (1) | RU2375362C2 (https=) |
| SI (1) | SI1729777T1 (https=) |
| TW (1) | TW200538100A (https=) |
| UA (1) | UA89773C2 (https=) |
| WO (1) | WO2005102352A1 (https=) |
| ZA (1) | ZA200608305B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA83666C2 (ru) * | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
| EP1792618A1 (en) * | 2005-11-30 | 2007-06-06 | Rainer Freynhagen | R-mirtazapine for the treatment of pain |
| TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
| CN104095824B (zh) * | 2013-04-09 | 2016-08-31 | 上海信谊万象药业股份有限公司 | 一种米氮平缓释片及其制备方法 |
| PL3261645T3 (pl) | 2015-02-27 | 2021-12-06 | Dechra Limited | Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów |
| CN111053735A (zh) * | 2020-02-25 | 2020-04-24 | 上海阶平医院管理有限公司 | 一种治疗失眠的冷敷凝胶 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| US4193828A (en) * | 1976-07-27 | 1980-03-18 | Fiber Materials, Inc. | Method of forming carbon composites |
| US4515792A (en) * | 1982-09-30 | 1985-05-07 | Ciba-Geigy Corporation | Tetracyclic heterocycles and antidepressant compositions thereof |
| EP0813873B1 (en) * | 1996-06-19 | 2002-02-13 | Akzo Nobel N.V. | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
| IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
| WO1999051237A1 (en) * | 1998-04-02 | 1999-10-14 | Akzo Nobel N.V. | Oral liquid antidepressant solution |
| WO2001000196A2 (en) * | 1999-06-25 | 2001-01-04 | University Of South Florida | Mirtazapine for weight gain in wasting diseases |
| US6281207B1 (en) * | 1999-09-15 | 2001-08-28 | Reed Richter | Treatment of movement disorders by administration of mirtazapine |
| WO2001042239A1 (en) * | 1999-12-13 | 2001-06-14 | Sumika Fine Chemicals Co., Ltd. | Process for the preparation of a pyridinemethanol compound |
| SK14162002A3 (sk) * | 2000-04-05 | 2003-03-04 | Akzo Nobel N.V. | Kombinácia obsahujúca paracetamol alebo nesteroidné protizápalové liečivo, použitie mirtazapínu, paracetamolu a pacientský balíček |
-
2005
- 2005-04-12 TW TW094111559A patent/TW200538100A/zh unknown
- 2005-04-19 CN CN2005800116628A patent/CN1942191B/zh not_active Expired - Fee Related
- 2005-04-19 SI SI200530673T patent/SI1729777T1/sl unknown
- 2005-04-19 RS RSP-2009/0164A patent/RS50764B/sr unknown
- 2005-04-19 UA UAA200610312A patent/UA89773C2/ru unknown
- 2005-04-19 RU RU2006140988/04A patent/RU2375362C2/ru not_active IP Right Cessation
- 2005-04-19 EP EP05740221A patent/EP1729777B1/en not_active Expired - Lifetime
- 2005-04-19 AU AU2005235383A patent/AU2005235383B2/en not_active Expired
- 2005-04-19 PL PL05740221T patent/PL1729777T3/pl unknown
- 2005-04-19 CN CN201010174000A patent/CN101824035A/zh active Pending
- 2005-04-19 MY MYPI20051731A patent/MY144899A/en unknown
- 2005-04-19 WO PCT/EP2005/051714 patent/WO2005102352A1/en not_active Ceased
- 2005-04-19 PT PT05740221T patent/PT1729777E/pt unknown
- 2005-04-19 MX MXPA06011830A patent/MXPA06011830A/es not_active IP Right Cessation
- 2005-04-19 HR HR20090190T patent/HRP20090190T1/xx unknown
- 2005-04-19 US US11/547,152 patent/US20070111993A1/en not_active Abandoned
- 2005-04-19 CA CA2561281A patent/CA2561281C/en not_active Expired - Fee Related
- 2005-04-19 DE DE602005013066T patent/DE602005013066D1/de not_active Expired - Lifetime
- 2005-04-19 AT AT05740221T patent/ATE424210T1/de active
- 2005-04-19 ES ES05740221T patent/ES2321961T3/es not_active Expired - Lifetime
- 2005-04-19 BR BRPI0509953-6A patent/BRPI0509953A/pt not_active IP Right Cessation
- 2005-04-19 DK DK05740221T patent/DK1729777T3/da active
- 2005-04-19 JP JP2007508904A patent/JP5260959B2/ja not_active Expired - Fee Related
- 2005-04-19 NZ NZ550052A patent/NZ550052A/en unknown
- 2005-04-20 PE PE2005000439A patent/PE20060400A1/es not_active Application Discontinuation
- 2005-04-20 AR ARP050101549A patent/AR049028A1/es unknown
-
2006
- 2006-09-20 IL IL178201A patent/IL178201A/en not_active IP Right Cessation
- 2006-10-05 ZA ZA200608305A patent/ZA200608305B/xx unknown
- 2006-10-19 EC EC2006006938A patent/ECSP066938A/es unknown
- 2006-11-03 NO NO20065077A patent/NO20065077L/no not_active Application Discontinuation
- 2006-11-21 LV LVP-06-130A patent/LV13556B/lv unknown
-
2009
- 2009-05-05 CY CY20091100481T patent/CY1109018T1/el unknown
-
2013
- 2013-03-08 JP JP2013046645A patent/JP2013136626A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301113I1 (nl) | Tucatinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout of solvaat | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| MX2007002189A (es) | Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos. | |
| ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
| ATE526318T1 (de) | Farnesoid-x-rezeptor-agonisten | |
| GB2453058A (en) | Kinase antagonists | |
| AP2006003795A0 (en) | 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors | |
| CY1110026T1 (el) | Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων | |
| UA95768C2 (ru) | Антагонисты мускариновых рецепторов ацетилхолина | |
| EP2617431A3 (en) | Polypeptide inhibitors of HSP27 kinase and uses therefor | |
| CY1111389T1 (el) | Φαρμακευτικες ενωσεις που περιεχουν ιματινιμπη και ενα επιβραδυντικο εκλυσης | |
| CY1109018T1 (el) | Φαρμακευτικη συνθεση που περιεχει ενα αλας μιρταζαπινης | |
| ATE413162T1 (de) | Pharmazeutische zusammensetzungen zur sicheren verabreichung von bei der behandlung von drogenabhängigkeit verwendeten arzneimitteln | |
| EP1906968A4 (en) | NEW SCHEMES FOR ORAL MONOPHASIC CONTRAZEPTIVA | |
| CY1105980T1 (el) | Βελτιωμενη διαδικασια παρασκευης υδροβρωμικου αλατος του αλφα-πολυμορφικου ελετριπτανιου | |
| EA200501697A1 (ru) | Дозируемая форма, содержащая пантопразол в качестве активного ингредиента | |
| WO2007056625A3 (en) | Thienopyridine b-raf kinase inhibitors | |
| BRPI0615141A2 (pt) | inibidores pentacìclicos de quinase | |
| CL2007001738A1 (es) | Compuestos derivados de cianopiridinas; composicion farmaceutica; y uso para el tratamiento o inhibicion de un trastorno mediado por una proteina quinasa, tal como enfermedad autoinmune e inflamatoria. | |
| CL2007001737A1 (es) | Compuestos derivados de cianopiridinas; inhibidores de proteina quinasa;composicion farmaceutica;y uso para el tratamiento o inhibicion de un trastorno mediado por una proteina quinasa,tal como enfermedad autoinmune e inflamatoria. | |
| UA91988C2 (ru) | Фармацевтическая композиция на основе антагонистов nk2 для применения в педиатрии | |
| UA92180C2 (en) | Benzimidazole thiophene compounds as plk inhibitors | |
| CY1108865T1 (el) | Υποκατεστημενες 2,5-διαμινομευθυλο-1η-πυρρολες | |
| DE60303363D1 (de) | Verfahren zur herstellung von 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinon | |
| WO2008129004A3 (en) | Heterocyclic compounds containing the morpholine nucleus their preparation and use |